PTPRC and neoplasm: Notably, evaluation of neoplastic cells at T60 revealed a still low tumor burden with 0.7 × 103/ml SS cells representing 39% of CD4+ T cells (2 × 103/ml) (Figure 1D) and 16% of CD45+ leukocytes (4.4 × 103, data not shown).